All stories tagged :

Pr Newswire

4DMT to Participate in Chardan’s 9th Annual Genetic Medicines Conference

Tháng 10 14

Provectus Biopharmaceuticals Announces Investor Webinar for 2024 Annual Meeting of Stockholders

1 năm ago

Araris Biotech AG Appoints Dr. Ulf Grawunder to Scientific Advisory Board

1 năm ago

Conduit Pharmaceuticals to Join Russell 3000® Index

1 năm ago

Omdia: OLED materials market will resume the growth to reach over...

1 năm ago

Concordia International School Shanghai Named in Top 10 Shortlist for World’s...

1 năm ago

Venture Global Announces Landmark Energy Security Agreement with DTEK of Ukraine

1 năm ago

D.R. Horton Offers Canadian Solar PV Panels and Residential Batteries to...

1 năm ago

Sirnaomics Demonstrates Strong Antitumor Activity of Its Novel Oligonucleotide-ChemoDrug Conjugate in...

1 năm ago

Alterity Therapeutics to Present at the MST Access ‘Hidden Gems in...

1 năm ago

Connect Biopharma Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

1 năm ago

1 2 3 … 753 754 755 756 757 758 759 … 761 762 763 Page 756 of 763

Featured

Opus Genetics to Participate in Chardan’s 9th Annual Genetic Medicines Conference

10 giờ ago

Hawx Services Celebrates Serving 14 States Across Nationwide

10 giờ ago

AICB Launches FSF Xcel: Malaysia’s First Industry-Wide Skills Assessment Platform to...

10 giờ ago

Morgan Stanley Raises JOYY (JOYY.US) Target Price from US$40 to US$62...

10 giờ ago

10 giờ ago

Opus Genetics to Participate in Chardan’s 9th Annual Genetic Medicines Conference

RESEARCH TRIANGLE PARK, N.C., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD) (the “Company” or “Opus Genetics”), a clinical-stage biopharmaceutical company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and small molecule therapies for other ophthalmic disorders, announced today that Ash...